All News

RheumNow Podcast square

T2T Debate - A Prologue with Dr. Marty Bergman

d Jack Cush, MD

Drs. Jack Cush and Martin Bergman review the topic of treat-to-target (T2T) management in rheumatology.



Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022.

Read Article
Feet, foot

Pre-clinical RA: starting off the wrong foot

d Aurelie Najm, MD, PhD

Patients with clinically suspect arthralgia can represent a challenge for clinicians, in a sense that there are not yet reliable markers to predict evolution to clinical RA nor enough evidence to support routine prescription of conventional synthetic DMARDS or biologic treatments in this setting.

Read Article
obesity.knee_.arthritis.jpg

Genes and Obesity Tied to Higher Gout Risk in Women

d Jack Cush, MD

Excess adiposity and genetic predisposition both contributed to risk of gout among U.S. women, with the risks being highest when both factors are present, a large prospective study found.

Read Article
ICYMI: TNF inhibitors and radiographic progression in axSpA A remaining challenge for clinicians is the ability to delay, if not completely stop, structural progression in patients with (ax-Spa, whether they are diagnosed with -axSpa or nr-axSpA disease. https://t.co/H0Fr54PwOP https://t.co/tFZJUr1j4B

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI:CDC and the ICD-10 Coordination and Maintenance Committee has assigned a diagnostic code for non-radiographic axial spondyloarthritis (nr-axSpA) == M45.A

Dr. John Cush RheumNow ( View Tweet)

FDA Puts Boxed Warnings on JAK Inhibitors Based on the safety review of tofacitinib in Pfizer's Oral Surveillance study, the FDA has formalized the recommendation that patients should be started on a TNF inhibitor (TNFi) before trying a JAK inhibitor. https://t.co/bXZ4Yedyyv https://t.co/tsvHOtIEK0

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Risks associated with mortality in VEXAS https://t.co/mpAc5shaMq https://t.co/FdOQcfwusp

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Zoom Fatigue is real. Study shows fatigue is from being on-cam that triggers self-presentation - the needs to monitor how you look to others; more common in women. Suggest: reduce monitor/image size & Turn off Self view (avoid self evaluation) https://t.co/vS8tJv9Kpd https://t.co/F7mHdYgOXy

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast up! Drs. Jack Cush and Martin Bergman review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. https://t.co/oe6hsAq2KG https://t.co/1sbTmd9cnV

Links:

Dr. John Cush RheumNow ( View Tweet)
Download Available! The Scary Side of Steroid. Log in and download today. https://t.co/sYVWGTVHgx https://t.co/NIbi49SJEo

Links:

Dr. John Cush RheumNow ( View Tweet)
AURORA 2 results were presented at #ACR21 - a continuation study of voclosporin in 116 active Lupus Nephritis pts randomized to either PBO or voclosporin. After 36 mos the VOC group had stable GFR and reduction in proteinuria https://t.co/O7G1dCIzbP

Links:

Dr. John Cush RheumNow ( View Tweet)

ASK CUSH ANYTHING! Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/tl3Nkxdv0B https://t.co/WwxgWGuVcC

Links:

Dr. John Cush RheumNow ( View Tweet)
Check out our blog by Dr. Kathryn Dao ( @KDAO2011) on "Redefining Aging." https://t.co/GbE77GTa0y https://t.co/e2GYETqsUR

Links:

Dr. John Cush RheumNow ( View Tweet)
CBD and Opioids in PsA : Dr. Eric Ruderman ( @JointMD) reviews abstract #1456 and #1777 presented at the ACR21 annual meeting. https://t.co/ZATSfzqj51 https://t.co/dhFwgS9b6J

Links:

Dr. John Cush RheumNow ( View Tweet)
Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions? https://t.co/RbOlrnW54O https://t.co/iDlqwv32zs

Links:

Dr. John Cush RheumNow ( View Tweet)
Zoom Fatigue is real. Study shows fatigue is from being on-cam that triggers self-presentation - the needs to monitor how you look to others; more common in women. Suggest: reduce monitor/image size & Turn off Self view (avoid self evaluation) https://t.co/KYi8bMKURy https://t.co/8fUqdpe6ia

Links:

Dr. John Cush RheumNow ( View Tweet)
BMS has announced they have filed a new drug application with the FDA and EMA for Deucravacitinib, a TYK2 inhibitor, to treat adults with moderate to severe plaque psoriasis. (w/ a PDUFA goal date of 9/10/2022) https://t.co/w5YmRYdXm4

Links:

Dr. John Cush RheumNow ( View Tweet)

Improving Our Everyday RA Practice https://t.co/eGPRMBGFjh https://t.co/y49x8MX4dK

Links:

Dr. John Cush RheumNow ( View Tweet)
The Gift of Gab: "RHEUM" Dr. Eric Dein interviews Professor Zeide and Dr. Jason Liebowitz about a lively ACR21 talk called, "The Gift of Gab," which guided attendees on how to improve their communications. https://t.co/fWOETKqQeP https://t.co/5b5rXzEAaQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Cognitive Function and Rheumatoid Arthritis: Dr. Akhil Sood Interviews Dr. Elena Myasoedova https://t.co/k3SBwEg0WH https://t.co/1eEBUQdMAa

Links:

Dr. John Cush RheumNow ( View Tweet)
×